Where I see patients (2)
My reviews
Selected research
-
Atezolizumab Plus Magrolimab, Niraparib, or Tocilizumab in Platinum-Refractory Metastatic Urothelial Carcinoma: A Phase Ib/II Open-Label, Randomized Umbrella Study.
Clinical cancer research : an official journal of the American Association for Cancer Research
-
Enfortumab Vedotin With or Without Pembrolizumab in Cisplatin-Ineligible Patients With Previously Untreated Locally Advanced or Metastatic Urothelial Cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology
-
Engaging Men of Diverse Racial and Ethnic Groups With Advanced Prostate Cancer in the Design of an mHealth Diet and Exercise Intervention: Focus Group Study.
JMIR cancer
Clinical trials
Study Evaluating the Efficacy and Safety of Multiple Immunotherapy-Based Treatments and Combina...
Objective response rate, defined as the proportion of participants with a CR or PR on two consecutive occasions >=4 weeks apart during Stage 1, as determined by the investigator according to RECIST v1.1.
Recruiting
5.0